KARUNA THERAPEUTICS INC (KRTX)
US48576A1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 69% to KRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 329.12. This target is -0.22% below the current price.
KRTX was analyzed by 23 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about KRTX.
In the previous month the buy percentage consensus was at a similar level.
KRTX was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-14 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-03-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-02-20 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-01-26 | Mizuho | Downgrade | Buy -> Neutral |
| 2024-01-17 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-12-28 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-12-26 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-12-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-12-22 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2023-12-22 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-12-22 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-12-12 | Deutsche Bank | Initiate | Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-17 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-03 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-11-03 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-09-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | B of A Securities | Maintains | Buy -> Buy |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-08-22 | Wells Fargo | Initiate | Overweight |
| 2023-08-04 | Mizuho | Maintains | Buy -> Buy |
| 2023-08-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-04 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-20 | Morgan Stanley | Initiate | Overweight |
| 2023-07-13 | William Blair | Maintains | Outperform -> Outperform |
| 2023-06-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-06-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |